100 related articles for article (PubMed ID: 12153171)
41. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome.
Tibiletti MG; Martin V; Bernasconi B; Del Curto B; Pecciarini L; Uccella S; Pruneri G; Ponzoni M; Mazzucchelli L; Martinelli G; Ferreri AJ; Pinotti G; Assanelli A; Scandurra M; Doglioni C; Zucca E; Capella C; Bertoni F
Hum Pathol; 2009 May; 40(5):645-52. PubMed ID: 19144384
[TBL] [Abstract][Full Text] [Related]
42. Establishment of a human cell line (SKI-DLCL-1) with a t(1;14)(q21;q32) translocation from the ascites of a patient with diffuse large cell lymphoma.
Goy A; Gilles F; Remache Y; Filippa D; Portlock CS; Jhanwar SC; Zelenetz AD
Leuk Lymphoma; 2001 Jan; 40(3-4):419-23. PubMed ID: 11426565
[TBL] [Abstract][Full Text] [Related]
43. Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma.
Raghoebier S; Kramer MH; van Krieken JH; de Jong D; Limpens J; Kluin-Nelemans JC; van Ommen GJ; Kluin PM
Blood; 1991 Nov; 78(10):2680-5. PubMed ID: 1824261
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of clonal diversity of immunoglobulin gene rearrangements in patients with diffuse large B-cell lymphoma.
Yang MH; Yen CC; Chiang SC; Bai LY; Lee KD; Hsiao LT; Chao TC; Wang WS; Liu JH; Chiou TJ; Chen PM
Oncol Rep; 2005 Mar; 13(3):503-8. PubMed ID: 15706425
[TBL] [Abstract][Full Text] [Related]
45. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
Huebner-Chan D; Fernandes B; Yang G; Lim MS
Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
[TBL] [Abstract][Full Text] [Related]
46. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene.
Akasaka T; Akasaka H; Ueda C; Yonetani N; Maesako Y; Shimizu A; Yamabe H; Fukuhara S; Uchiyama T; Ohno H
J Clin Oncol; 2000 Feb; 18(3):510-18. PubMed ID: 10653866
[TBL] [Abstract][Full Text] [Related]
47. [Genetic abnormalities in B cell neoplasms: special reference to diffuse large cell lymphoma].
Ohno H; Hayashi T
Rinsho Ketsueki; 1996 May; 37(5):404-7. PubMed ID: 8691584
[No Abstract] [Full Text] [Related]
48. [Diffuse large B-cell lymphoma mainly involving the heart and showing t(8;14) (q24;q32) with c-myc rearrangement].
Takai K; Sanada M; Hirose Y; Shibuya H
Rinsho Ketsueki; 1997 Sep; 38(9):757-62. PubMed ID: 9364867
[TBL] [Abstract][Full Text] [Related]
49. [Primary splenic lymphoma with t(3;14)(q27;q32) chromosomal abnormality and rearrangement of BCL-6 gene].
Yata K; Wada H; Otsuki T; Sadahira Y; Sugihara T; Yamada O; Yawata Y
Rinsho Ketsueki; 1999 Jul; 40(7):587-92. PubMed ID: 10483143
[TBL] [Abstract][Full Text] [Related]
50. High frequency and strong prognostic relevance of O6-methylguanine DNA methyltransferase silencing in diffuse large B-cell lymphomas from the Middle East.
Al-Kuraya K; Narayanappa R; Siraj AK; Al-Dayel F; Ezzat A; El Solh H; Al-Jommah N; Sauter G; Simon R
Hum Pathol; 2006 Jun; 37(6):742-8. PubMed ID: 16733216
[TBL] [Abstract][Full Text] [Related]
51. [Clinical characteristics of high-grade B-cell lymphomas with rearrangement of MYC, bcl-6 and bcl-2].
Gong JY; Zhang YZ; Zhang JD; Zhang W; Li JQ; Ru K; Liu EB
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):14-18. PubMed ID: 29325245
[No Abstract] [Full Text] [Related]
52. Frequency of bcl-2 gene rearrangement in B-cell Non-Hodgkin's lymphoma.
Arif A; Jamal S; Mushtaq S; Ahmed S; Mubarik A
Asian Pac J Cancer Prev; 2009; 10(2):237-40. PubMed ID: 19537891
[TBL] [Abstract][Full Text] [Related]
53. [Expression of CD68, cyclin D1 and rearrangement of bcl-6 gene are adverse prognostic factors in diffuse large B-cell lymphoma].
Liang X; Wang J; Bai W; Sun R
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):559-64. PubMed ID: 26705179
[TBL] [Abstract][Full Text] [Related]
54. Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms.
Muramatsu M; Akasaka T; Kadowaki N; Ohno H; Fukuhara S; Okuma M
Leukemia; 1997 Apr; 11 Suppl 3():318-20. PubMed ID: 9209377
[TBL] [Abstract][Full Text] [Related]
55. [BCL-2 gene in lymphocytic malignancy].
Seto M; Yamamoto K; Osada H; Ueda R
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1106-11. PubMed ID: 2053769
[TBL] [Abstract][Full Text] [Related]
56. bcl-6 in lymphoma--sorting out a wastebasket?
Kluin PM
N Engl J Med; 1994 Jul; 331(2):116-8. PubMed ID: 8208254
[No Abstract] [Full Text] [Related]
57. Chromosomal and gene amplification in diffuse large B-cell lymphoma.
Rao PH; Houldsworth J; Dyomina K; Parsa NZ; Cigudosa JC; Louie DC; Popplewell L; Offit K; Jhanwar SC; Chaganti RS
Blood; 1998 Jul; 92(1):234-40. PubMed ID: 9639522
[TBL] [Abstract][Full Text] [Related]
58. Towards new prognostic factors in diffuse large cell non-Hodgkin's lymphoma.
Salles G
Ann Oncol; 1996 Dec; 7(10):993-6. PubMed ID: 9037355
[No Abstract] [Full Text] [Related]
59. Translocation t(1;21)(q21;p11) with trisomies X and 1q in a diffuse large B-cell lymphoma.
Gladstone B; Kadam PR; Balsara BR; Gopal R; Parikh PM; Advani SH
Cancer Genet Cytogenet; 1994 Oct; 77(1):91. PubMed ID: 7923091
[No Abstract] [Full Text] [Related]
60. The molecular biology of B-cell lymphoma: clinicopathologic implications.
Kluin PM; van Krieken JH
Ann Hematol; 1991 Apr; 62(4):95-102. PubMed ID: 2031977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
